Within the last two decades, the emergence and global impact of three highly pathogenic coronaviruses of zoonotic origin have compelled rapid attention to anthropogenic drivers of disease evolution ...
Single-domain antibodies, or nanobodies, have recently been thrust into the spotlight as a potential treatment for COVID-19. In fact, a COVID-19 nanobody-based treatment developed by the Beroni Group, ...
Sarbecoviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), pose a significant health risk burden. Factors like genetic diversity, natural reservoirs, and frequent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results